IMPORTANCE Patients hospitalized for chronic obstructive pulmonary disease (COPD) exacerbations have high rehospitalization rates and reduced quality of life. OBJECTIVE To evaluate whether a hospital-initiated program that combined transition and long-term self-management support for patients hospitalized due to COPD and their family caregivers can improve outcomes. DESIGN, SETTING, AND PARTICIPANTS Single-site randomized clinical trial conducted in Baltimore, Maryland, with 240 participants. Participants were patients hospitalized due to COPD, randomized to intervention or usual care, and followed up for 6 months after hospital discharge.
C hronic obstructive pulmonary disease (COPD) was the fourth leading cause of death in the United States in 2016, and has been a leading cause of morbidity and disability. [1] [2] [3] Patients with COPD receiving emergency department (ED) and hospital care are more likely to have lower education and income and comorbidities. 4 A review of discharge bundle interventions to improve outcomes of hospitalized patients with COPD showed a modest effect on reducing hospitalizations, and no effects on mortality or quality of life. 5 Transitional care studies of patients with COPD are few, often limited to addressing postacute care needs in the 30-day postdischarge period, and did not focus on long-term chronic disease self-management skills. [6] [7] [8] [9] [10] However, this may be insufficient for improving patient outcomes and reducing future acute care use.
Studies on COPD self-management support, mostly conducted in outpatient settings, have demonstrated improvements in health-related quality of life (HRQOL) and reductions in COPD-related acute care events. 11, 12 These studies have included ongoing education, action plans, and longterm self-management support. [11] [12] [13] [14] To our knowledge, no similar interventions have been tested among hospitalized patients with COPD, although hospitalization may offer a unique opportunity to engage patients and family caregivers in self-management of this condition.
In this study, a patient-centered, hospital-initiated, 3-month program that combines transition support and chronic disease self-management (the BREATHE Program) was developed and evaluated. The program aimed to improve quality of life and reduce acute care use among patients with COPD. 15 The study's primary hypothesis was that compared with participants who received usual transitional care, participants randomized to receive this program would have a lower number of COPD-related acute care events and better HRQOL at 6 months after hospital discharge. 15 
Methods
The Johns Hopkins Institutional Review Board approved this study. Written consent was obtained from all participants. Detailed study methods are described elsewhere. 15 The trial protocol and statistical analysis plans are available in Supplement 1 and Supplement 2, respectively.
Study Design and Setting
This single-blinded randomized clinical trial had 2 groups (intervention and usual transitional care). The study took place at Johns Hopkins Bayview Medical Center, a 447-bed academic community hospital in Baltimore, Maryland, that serves the largest number of patients with COPD within the Johns Hopkins Health System (JHHS). Most hospitalized patients with COPD are treated at 1 of 4 medical units at the hospital. All patients admitted to these units starting in March 2015 were screened for eligibility. 15 Enrollment ended in May 2016 and follow-up ended in December 2016.
Patients were eligible if they were either admitted to the Johns Hopkins Bayview Medical Center with a diagnosis of acute COPD exacerbation or had a previous COPD diagnosis and were receiving additional treatment to control COPD symptoms in the current hospitalization. 15 Additional eligibility criteria included being aged older than 40 years, having a smoking history of more than 10 pack-years, understanding the English language, having no terminal illness (<6-month life expectancy) other than COPD, having no severe cognitive dysfunction (able to follow simple instructions), not being homeless, and expecting discharge to home. 15 Eligibility was confirmed via medical record review and clinician confirmation. No participants were excluded based on discharge diagnosis.
Participants were randomized in a 1:1 ratio to either study group based on a pregenerated sequence of assignments. Randomization was stratified by hospital unit, and a computer algorithm was used to perform a blocked randomization assignment within strata with randomly selected block sizes of 2, 4, or 6. Data collectors and outcomes assessors were blinded to group allocation; however, due to the nature of the intervention, participants and clinicians were not blinded.
Study Group Descriptions

Intervention Group
The study intervention was co-developed with patients who have COPD, caregivers, and other stakeholders, with a focus on improving hospitalized patients' HRQOL and reducing their future need for seeking emergency care. 15, 16 It included 3 components deemed necessary and complementary to achieving study goals 15 : 1. Transition support to try to ensure that patients and caregivers were prepared for discharge and understood the postdischarge plan of care. 2. Individualized COPD self-management support to help patients take medications correctly, recognize exacerbations signs and follow action plan (eAppendix 1 in Supplement 3), practice breathing exercises and energy conservation techniques, maintain an active lifestyle, seek help as needed, and stop smoking. 3. Facilitated access to community programs and treatment services.
The intervention was delivered by COPD nurses (ie, nurses with special training on supporting patients with COPD using standardized tools). The nurses met with the patient (and caregiver whenever possible) during the hospital stay and for 3 months after discharge. They provided self-management support and addressed barriers to care. The program followed a patient-centered partnership approach and was delivered during a series of sessions held at the hospital and after discharge via home visit or telephone. 15 
Comparison Group
Participants in the comparison group received the usual transitional care provided at the study site. This included assigning a general transition coach to follow up the patient for 30 days after discharge, focusing on adherence to the discharge plan, and connecting to outpatient care. eTable 1 in Supplement 3 compares the intervention and usual care groups.
Data Collection
Patient consent, baseline assessment, and randomization were completed during hospital stay. The assessment included patient report on education, income, patient activation measure (assesses an individual's knowledge, skill, and confidence for managing their health), 16 comorbidities, and race/ethnicity (collected to report on minorities' representation in randomized clinical trials, using 2 separate questions with specified response categories). Data collection telephone calls were conducted at 1 week and 1, 3, and 6 months after discharge. Acute care visits were assessed via medical record review for all visits within JHHS. Participants were asked at each telephone call if they had visited any non-JHHS hospital or ED and, if so, their records were requested and reviewed. For participants who could not be reached at 6 months, visits within the JHHS and any outside visits reported previously were reviewed. Records of each visit were independently reviewed by 2 physicians to determine whether the visit was COPD-related using predefined criteria. 15 A third physician adjudicated any unresolved conflicts. Data on deaths were collected via medical record and death certificate reviews. 15 
Outcomes
The study's prespecified primary outcome was the number of COPD-related acute care events, defined as hospitalizations and ED visits, per participant over the 6 months after discharge. A co-primary outcome was the change in participants' HRQOL as measured by the St George's Respiratory Questionnaire (SGRQ) score at 6 months after discharge. The COPD-related events outcome was the primary design variable to power the study, and we would not have considered this study positive without inferring a benefit on this outcome. The SGRQ outcome was chosen as a key supportive outcome given its patient-centeredness and importance to interpreting intervention effects. The SGRQ is a valid instrument for measuring HRQOL in patients with respiratory disease, with a total score and scores for symptom, physical activity, and impact domains (score range, 0 [best]-100
[worst]). 17 Total score's minimum clinically important difference is 4 points. 17, 18 Prespecified secondary outcomes were (1) 6-month mortality rate and (2) time to death or first COPD-related hospitalization or ED visit. As part of post hoc supplementary analyses, the following outcomes were compared: (1) mean number of COPD-related and all-cause acute care events per participant and the individual components (hospital and ED visits separately) at each time point; (2) percentage of participants who had at least 1 COPD-related acute care event;
(3) change in participants' SGRQ domain scores; and (4) percentage of participants whose HRQOL improved, stayed the same, or deteriorated within each group.
Intervention implementation was tracked and adverse events, including hospitalizations, deaths, and falls resulting in an acute care visit, were monitored.
Statistical Analyses
Sample size was calculated to detect a difference of 0.25 in the mean cumulative number of COPD-related visits per participant between study groups, with 80% power and type I error of .05 (2-sided). The 0.25 difference, which was based on results of an earlier COPD self-management trial, is considered clinically meaningful. 13, [19] [20] [21] The estimated sample size was 120 per group. 15 Unadjusted analyses of the treatment effect under intention to treat were performed using negative binomial regression for the cumulative count of events, and linear regression for change in SGRQ total and domain scores. Additional analyses were conducted, adjusting for baseline SGRQ and unit for change in SGRQ scores and predictors of hospitalization (age, home oxygen use, and hospitalization within past year) and unit for acute care event counts. [22] [23] [24] All analyses included robust estimates of variance and accounted for within-unit correlation. Normality and homoskedasticity of residuals were evaluated for linear regression models. SGRQ scores for patients who died were substituted with 100. The effect of missingness on primary outcomes was evaluated by comparing the patient characteristics of those with and without the missing outcome. Survival analyses and Cox proportional hazard models were used to compare the probability of not dying or having a COPD-related acute care event, by study group, adjusting for predictors of hospitalization. The proportional hazard assumption was evaluated with a test of a zero slope for the log-hazard ratio.
Post hoc analyses included logistic regression to compare the odds of having at least 1 COPD-related event, and responder analysis of participants whose HRQOL improved, stayed the same, or deteriorated (categorized change in SGRQ score as improved if ≤−4, and deteriorated if ≥4). 17,18,21 A sensitivity analysis was performed to evaluate the effect of missingness on HRQOL using a mixed-effects generalized linear model with robust variance estimates, clustering within hospital units, with patient as random effect, and using all available SGRQ total scores (baseline, 3 months, and 6 months).
Post hoc exploratory subgroup analyses to assess heterogeneity of treatment effects were performed to evaluate the difference in treatment effect in subgroups of patients whose characteristics might have affected the primary outcome. The analyses were performed for the subgrouping variables of age, sex, marital status, home oxygen use, heart failure diagnosis, and baseline patient activation level. The treatment effects were estimated by the inclusion of an interaction term in a negative binomial regression model, standardizing with inverse probability weighting to address the correlation between the multiple subgrouping variables. 25 Analysis was performed in Stata versions 14 and 15 (StataCorp). Main analyses were prespecified. 15 Statistical significance was considered for P < .05 (2-sided) . No adjustment for multiple comparisons was performed, and therefore all analyses of secondary and other supplementary outcomes should be considered exploratory. Figure 1 depicts participant recruitment, enrollment, and follow-up. Of 802 patients screened for participation, 417 met eligibility criteria and 240 provided consent. Baseline characteristics of the participants were similar between the study groups, except for a higher percentage of smoking, home oxygen use, heart failure diagnosis, and use of combined β-agonist/ anticholinergic and short-acting β-agonists in the intervention group ( Table 1) .
Results
No data were missing for baseline covariates. The mean (SD) participant age was 64.9 (9.8) years and most participants were white (82.5%) and female (61.7%). eTable 2 in Supplement 3 summarizes study participants' comorbidities. The cumulative number of events at 1, 3, and 6 months after discharge were counted based on medical record review for participants living at those time points. Sixteen participants (14%) in the usual care group and 15 participants (13%) in the intervention group were lost to followup. No significant differences were found in baseline characteristics of these participants compared with the overall study sample.
Primary Outcomes
Effect on COPD-Related Acute Care Events The total number of COPD-related acute care events in this study was 238 (196 COPD-related hospitalizations and 42 COPD-related ED visits). The study primary outcome was the number of COPD-related acute care events per patient over 6 months after discharge. This outcome was assessed for all participants living at 6 months (intervention: n = 112; usual care: n = 113). The mean number of COPD-related events per participant at 6 months was 1.40 (95% CI, 1.01-1.79) in the intervention group and 0.72 (95% CI, 0.45-0.97) in the usual care group (difference, 0.68 [95% CI, 0.22-1.15]; P = .004). 
Secondary Outcomes
There were 8 deaths (6.7%) in the intervention group and 7 deaths (5.8%) in the usual care group (P > .99). Figure 3 depicts the cumulative number of COPD-related and all-cause events per participant by event type and study group at 1, 3, and 6 months after discharge. The incidence rate ratio of COPD-related events at 6 months for the intervention compared with usual care group was 1.96 (95% CI, 1.57-2.43; P < .001) before adjustment and 1.59 (95% CI, 1.32-1.92; P < .001) after adjustment for age, home oxygen use, discharge unit, and hospitalization in the prior year. The incidence rates and incidence rate ratios of COPDrelated and all-cause events by event type and study group before and after adjustment are depicted in eTable 4 in Supplement 3. The treatment effect was similar after adjustment for age, home oxygen use, discharge unit, and hospitalization in prior year (eTable 4 in Supplement 3).
Supplementary Post Hoc Analyses
The percentage of participants who experienced at least 1 COPD-related acute care event was 52% in the intervention group and 38% in the usual care group (odds ratio, 1.74 [95% CI, 1.03-2.98]; P = .04). Of those participants, 22%, 10%, 5%, and 14% had 1, 2, 3, and 4 or more COPD-related acute care events in the intervention group compared with 20%, 12%, 3%, and 3% in the usual care group, respectively (Fisher exact P = .01). level 1 = patients tend to be overwhelmed and unprepared to play an active role in their own health; level 2 = patients lack knowledge and confidence for self-management; level 3 = patients are beginning to take action, but lack confidence and skill to support behaviors; and level 4 = patients have adopted many of the behaviors to support their health, but may not be able to maintain them in the face of life stressors. d Charlson Comorbidity Index score ranges from 0 to 29; higher numbers indicate increased morbidity. Table 2 depicts differences in SGRQ domain scores between study groups. There were no significant differences in domain scores. The responder analysis showed that at 6 months, the HRQOL improved, stayed the same, or deteriorated among 38%, 19%, and 43% of patients in the intervention group compared with 51%, 25%, and 24% of patients in the usual care group, respectively (Pearson χ 2 P = .03). eFigure 3 in Supplement 3 depicts a parallel line plot of change in SGRQ scores by study group. A sensitivity analysis, performed to assess the effect of missing values on HRQOL using mixed-effects generalized linear model, allowed for examination of 586 SGRQ total scores across 231 patients and showed findings that were consistent with the primary analysis. (Estimated differences in SGRQ at 6 months compared with baseline for the intervention and usual care groups were 2.51 [95% CI, −1.61 to 6.63] and −2.43 [95 % CI, −6.37 to 1.50], respectively; see the eAppendix 2 and eTable 5 in Supplement 3 for more details.)
The exploratory subgroup analyses assessing the heterogeneity of treatment effects found significant intervention interactions with sex and with patient activation level (eFigure 4 in Supplement 3). Further analysis looking at the 4 subgroups of men and women with high and low activation levels revealed a significant interaction (overall test of interaction terms P < .001). Both men and women with high activation levels had a higher number of acute care events in the intervention group compared with the control group, although this effect was more pronounced among men (incidence rate ratio for men, 8 
Intervention Implementation
The COPD nurse visited 103 of 120 participants at least once in the hospital. Intervention group participants had a mean of 6.1 sessions (interquartile range, 4-8) (eTable 7 in Supplement 3).
Adverse Events
Adverse events were reviewed at 3-to 6-month intervals. There were 339 hospitalizations and 3 falls resulting in acute care visits. No adverse events were attributed to the study intervention. There was no evidence of heteroskedasticity of residuals with respect to group (P = .22, .87, .70, and .12 for total, symptom, activity, and impact scores, respectively). d Data were available for patients as follows: total score: n = 91 in usual care, n = 88 in intervention; symptom score: n = 94 in usual care, n = 88 in intervention; activity score: n = 91 in usual care, n = 88 in intervention; and impact score: n = 93 in usual care, n = 88 in intervention. The median time to first event for the intervention group is 122 days (95% CI, 78-180) compared with greater than 180 days for the usual care group (exact value is not computed because it is beyond the 6-month observation period). Cox proportional hazards model adjusted for hospital unit, age, oxygen use, and prior hospitalization.
Research Original Investigation
Effect of Transitional Care and Long-term Self-management Support on Outcomes After Hospitalization 
Discussion
In a single-site randomized clinical trial of patients hospitalized due to COPD, a 3-month program that combined transition and long-term self-management support resulted in significantly greater COPD-related hospitalizations and ED visits.
There was no significant difference in HRQOL. COPD self-management interventions, mostly implemented in outpatient settings, have shown reductions in COPD-related hospitalizations but most excluded participants based on comorbidities and provided medical interventions (eg, steroid or antibiotics prescription for use as needed). 11 One study using a COPD action plan with selfinitiated treatment was stopped prematurely for concerns of increased mortality. 26 In the current study, patients with comorbidities were not excluded and the intervention offered no medical treatment services. The intervention, which was co-developed with patients, caregivers, and others (including clinicians of various disciplines and health care leaders), focused on engaging both patients and caregivers in COPD self-management. It included an action plan that focused on early recognition of signs and symptoms of acute exacerbations and contacting a physician early for those.
The increase in COPD-related acute care use in the intervention compared with usual care group found in this study was in the opposite direction from what had been hypothesized. This inconsistency necessarily raises a question about the validity of the study findings and means that study interpretation needs to be cautious and provisional.
If the findings represent a true effect, the post hoc subgroup analyses raise possible mechanisms, although these need to be considered speculative. The increase in acute care events was limited to patients with high activation status at baseline and was more common among men than women. Patients with greater activation may have responded to the intervention by being more vigilant about detecting signs of early exacerbations and taking action to get medical attention within 24 hours, as recommended by their action plan. Inability to access their regular physician within that timeframe, due to various reasons, could have led them to seek acute care services. In addition, increased communications with clinicians about exacerbation signs might have led to increased referrals to the emergency department (and subsequent hospitalizations). More acute care use by men than women may relate to less experience with seeking ambulatory care and lack of established connections with the health care system for routine care services. The latter has been demonstrated in other studies. 27, 28 Limitations This study has several limitations. First, the study was conducted at a single site, and therefore, the results may not be generalizable to all patients with COPD. Second, the study population included a high proportion of low-income and less-educated participants, and these participants may have greater challenges in accessing the health care system for urgent visits outside of coming to the emergency department. Third, there were small differences in the study groups at baseline (eg, higher percentages of current smokers and continuous home oxygen therapy use) that might have led to greater health care utilization in the intervention group. Fourth, for participants who could not be contacted at 6 months after discharge, it was not possible to measure their QOL and verify acute events treated outside the JHHS. However, these participants were similar between study groups and their baseline characteristics were not different from the rest of study participants. Fifth, spirometry evidence of airflow obstruction was not required for enrollment into the study and it is possible that some participants may have been incorrectly diagnosed as having COPD. Sixth, because the direction of the results were opposite of what was anticipated, the findings should be considered hypothesisgenerating rather than definitive.
Conclusions
In a single-site randomized clinical trial of patients hospitalized due to COPD, a 3-month program that combined transition and long-term self-management support resulted in significantly greater COPD-related hospitalizations and emergency department visits, without improvement in quality of life. Further research is needed to determine reasons for this unanticipated finding. The accuracy of the scientific record is one of the most important priorities for authors and editors. 1 To reflect this priority, JAMA issues corrections, retractions, retractions with replacement, and, in this issue, a retraction with republication of an article. 2 O n N ove m b e r 1 2 , 2 0 1 8, JAMA published the article titled "Effect of a Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Hospitalized Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial," 3 with an accompanying Editorial. 4 JAMA was notified by the authors of a major coding error that reversed the results, finding that the intervention was associated with harm rather than benefit. The authors have provided a detailed explanation of the error. 5 JAMA consulted peer reviewers who agreed that the corrected findings were important and, after additional internal review to assess validity, warranted publication in JAMA.
Because of the change in findings, the authors conducted additional analyses to elucidate potential sources of bias that could explain the unexpected results. These additional analyses, along with the context for interpreting the different findings, are why this paper is being published as a new article, and the original article is being retracted.
The new article, 6 an accompanying new Editorial, 7 and Letter of explanation from the authors 5 are in this issue of JAMA. The original Editorial 4 is hereby retracted. A Letter to the editor 8 (and a reply 9 ), which focused on the intervention and not the specific findings, has not been retracted but has been corrected.
Unexpected findings in all studies, and particularly in randomized clinical trials because of their potential effect on clinical care, require careful reading. In the study design, it was hypothesized that the intervention would improve health outcomes, but rather it appears to have been associated with harm. This finding was unexpected, and the various analyses that have been conducted to try to explain the results should be considered exploratory.
JAMA remains committed to ensuring an accurate scientific record. In most cases, identification of major errors has come from the study authors, who have notified JAMA of these errors after they were discovered when reusing the same database. We urge authors to continue to report errors in their own work, so that along with editors, they can jointly decide whether a correction, retraction, retraction with replacement, or retraction with republication is required.
